Our entire team is ready to continue servicing all customers without interruption, committing to providing exceptional support and customer satisfaction, even in times of uncertainty.
The largest biopharmaceutical company in India that enables access to high quality, advanced therapies for chronic diseases, has selected LifeSphere® eTMF as its electronic trial master file system.
Luye Pharma, a pharmaceutical company dedicated to the R&D, manufacturing, and sale of innovative medications, has selected LifeSphere as its next-generation signal detection tool.
The DIA 2020 Annual Meeting Is Now Virtual. ArisGlobal will be front and center with presentations covering both Safety and Clinical perspectives in Life Sciences process management.
The Evolving Role of CTMS in Risk Management takes a broad look at the challenges facing clinical trial management, how the clinical domain is changing, and how the industry can better respond.
A versatile Clinical Trial Management Solution, LifeSphere® CTMS10 contains great functionality and five key benefits, addressing a variety of challenges in the clinical product lifecycle.
Managing and Mastering Pharmacovigilance covers how LifeSphere Multivigilance 10 benefits small to medium-sized businesses by utilizing industry-standard practices and proper management processes.
ArisGlobal’s LifeSphere Mobile Has Evolved into LifeSphere Reporter. Here is What That Means for You.
A key offering in ArisGlobal’s LifeSphere platform, LifeSphere Reporter empowers field reps, provides fields teams and approved users with secure access, and easily integrates with LSMV10 and other systems.
ArisGlobal has created an Automation in Pharmacovigilance Knowledge Hub to help explain, in easily digestible terms, everything you need to know about automation in PV.
Time and again you hear the same refrain: “It will be in the next release”. But in the meantime, you’re struggling to cope because you need certain features and functionalities for your clinical trials management system. And right now, the CTMS...
By Danilo Pavlovic As both a conference attendee and ArisGlobal representative in our booth on the show floor at the recent Partnerships in Clinical Trials Europe, I had plenty of opportunity to sit in on sessions, talk to industry colleagues...
With declining R&D budgets, increased competition from larger CROs and patent expirations, emerging CROs have evolved from being non-core service providers to being integral partners in the earliest to the latest stages of the drug...
CRO industry grows as increasingly complex R&D trends demand advanced expertise Among today’s CRO, R&D trends, precision-based medicines and immunotherapies for smaller populations and treatments for rare diseases are driving...
I wrote a post a couple of months ago about the drawbacks of accessing multiple data sources. I discussed how it was essential for project managers to have the available technology, designed for usability that enables them to have the necessary visibility of their...
In today’s fast paced ‘all or nothing’ innovative solution-focused industry, clinical software repositories and data analytic solutions for data conformance tend to be complex and miles away from empowering the user with flexibility and ease of use. Time after time,...
Major Tobacco Manufacturer Selects LifeSphere® MultiVigilance to Automate All Global Internal Adverse Event Management Processes
A multinational tobacco products manufacturing company recently selected ArisGlobal’s LifeSphere® MultiVigilance 10, industry’s first and only automated adverse event platform for their global safety vigilance needs.
Linical a market-leading, midsized, global contract research organization (CRO) adopted ArisGlobal’s LifeSphere MultiVigilance as their primary global safety management system, industry’s first and only automated adverse event platform.
ArisGlobal announced it has made a number of new key leadership hires, with the express purpose of preparing for accelerated growth in North America, Europe, and Asia, and new product launches in 2020, according to President and CEO Sankesh Abbhi.
ArisGlobal and Soterius Extend Partnership with Global Delivery of LifeSphere® MultiVigilance and LifeSphere® Medical Information
ArisGlobal has expanded its partnership with Soterius, Inc., a global leader in providing drug safety and medical outsourcing services and solutions adding LifeSphere® MultiVigilance and LifeSphere® Medical Information to their service-oriented technology stack.
ArisGlobal’s LifeSphere MultiVigilance Goes Live with Top 5 Pharma, Delivering a Next-Generation Safety System to 2,300+ End Users
ArisGlobal successfully delivered the industry’s largest drug safety system implementation, going live on-time with its next-generation LifeSphere® MultiVigilance offering. LifeSphere MultiVigilance 10 is the industry’s only end-to-end safety system offering production-ready automation.
10 Life Sciences Companies Switch to ArisGlobal’s LifeSphere® MultiVigilance from Competing Safety Systems
ArisGlobal is proud to announce that ten life sciences companies have switched to its industry-leading LifeSphere® MultiVigilance drug safety system within the past 12 months. LifeSphere MultiVigilance is a next-generation, end-to-end safety system that has been developed in close partnership with industry leaders, including the FDA, Boehringer Ingelheim, Teva and AbbVie, among others.